Sugarloaf Wealth Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-150
| Closed | -$5K | – | 867 |
|
|
2022
Q2 | $5K | Hold |
150
| – | – | ﹤0.01% | 606 |
|
|
2022
Q1 | $5K | Hold |
150
| – | – | ﹤0.01% | 571 |
|
|
2021
Q4 | $4K | Hold |
150
| – | – | ﹤0.01% | 623 |
|
|
2021
Q3 | $4K | Sell |
150
-250
| -63% | -$6.67K | ﹤0.01% | 634 |
|
|
2021
Q2 | $14K | Hold |
400
| – | – | ﹤0.01% | 461 |
|
|
2021
Q1 | $16 | Hold |
400
| – | – | ﹤0.01% | 453 |
|
|
2020
Q4 | $17K | Buy |
400
+50
| +14% | +$2.13K | 0.01% | 415 |
|
|
2020
Q3 | $19K | Hold |
350
| – | – | 0.01% | 370 |
|
|
2020
Q2 | $22K | Hold |
350
| – | – | 0.01% | 341 |
|
|
2020
Q1 | $18K | Hold |
350
| – | – | 0.01% | 353 |
|
|
2019
Q4 | $28K | Buy |
+350
| New | +$28K | 0.01% | 325 |
|